Epstein-Barr virus protein kinase BGLF4 targets the nucleus through interaction with nucleoporins

Journal of Virology

Volumn 86, Issue 15, 2012, Pages 8072-8085

  Chang, Chou Wei ^a   Lee, Chung Pei ^a,b   Huang, Yu Hao ^a   Yang, Pei Wen ^a   Wang, Jiin Tarng ^a   Chen, Mei Ru ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BGLF4 PROTEIN; NUCLEOPORIN; NUCLEOPORIN 153; NUCLEOPORIN 62; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME LOCALIZATION; ENZYME STRUCTURE; FEMALE; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN TRANSPORT; STRUCTURE ANALYSIS;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SUBSTITUTION; CELL NUCLEUS; DNA REPLICATION; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; MEMBRANE GLYCOPROTEINS; MUTATION, MISSENSE; NUCLEAR PORE COMPLEX PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; VIRAL PROTEINS; VIRUS ASSEMBLY;

HUMAN HERPESVIRUS 4;

EID: 84864387451     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01058-12     Document Type: Article

References (66)

1. Adam SA, Marr RS, Gerace L. 1990. Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors. J. Cell Biol. 111:807-816.
2. Andrade MA, Petosa C, O'Donoghue SI, Muller CW, Bork P. 2001. Comparison of ARM and HEAT protein repeats. J. Mol. Biol. 309:1-18.
3. Asai R, et al. 2006. Epstein-Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylationdependent process and phosphorylates the viral immediate-early protein BZLF1. J. Virol. 80:5125-5134.
4. Baldwin AS, Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683.
5. Bayliss R, Littlewood T, Stewart M. 2000. Structural basis for the interaction between FxFG nucleoporin repeats and importin-beta in nuclear trafficking. Cell 102:99-108.
6. Chang Y, et al. 1999. Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J. Virol. 73:8857-8866.
7. Chee MS, Lawrence GL, Barrell BG. 1989. Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase. J. Gen. Virol. 70(Pt 5): 1151-1160.
8. Chen MR, Chang SJ, Huang H, Chen JY. 2000. A protein kinase activityassociated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro. J. Virol. 74:3093-3104.
9. Chuderland D, Konson A, Seger R. 2008. Identification and characterization of a general nuclear translocation signal in signaling proteins. Mol. Cell 31:850-861.
10. Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ. 2002. Proteomic analysis of the mammalian nuclear pore complex. J. Cell Biol. 158:915-927.
11. Davis LI, Blobel G. 1986. Identification and characterization of a nuclear pore complex protein. Cell 45:699-709.
12. Fagotto F, Gluck U, Gumbiner BM. 1998. Nuclear localization signalindependent and importin/karyopherin-independent nuclear import of beta-catenin. Curr. Biol. 8:181-190.
13. Fouchier RA, et al. 1998. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J. Virol. 72:6004-6013.
14. Gershburg E, Marschall M, Hong K, Pagano JS. 2004. Expression and localization of the Epstein-Barr virus-encoded protein kinase. J. Virol. 78:12140-12146.
15. Gershburg E, Pagano JS. 2008. Conserved herpesvirus protein kinases. Biochim. Biophys. Acta 1784:203-212.
16. Gershburg E, Raffa S, Torrisi MR, Pagano JS. 2007. Epstein-Barr virusencoded protein kinase (BGLF4) is involved in production of infectious virus. J. Virol. 81:5407-5412.
17. Gershburg S, Murphy L, Marschall M, Gershburg E. 2010. Key motifs in EBV (Epstein-Barr virus)-encoded protein kinase for phosphorylation activity and nuclear localization. Biochem. J. 431:227-235.
18. Gorlich D, Henklein P, Laskey RA, Hartmann E. 1996. A 41 amino acid motif in importin-alpha confers binding to importin-beta and hence transit into the nucleus. EMBO J. 15:1810-1817.
19. Hanks SK, Quinn AM. 1991. Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Methods Enzymol. 200:38-62.
20. Hawryluk-Gara LA, Platani M, Santarella R, Wozniak RW, Mattaj IW. 2008. Nup53 is required for nuclear envelope and nuclear pore complex assembly. Mol. Biol. Cell 19:1753-1762.
21. Hofemeister H, O'Hare P. 2008. Nuclear pore composition and gating in herpes simplex virus-infected cells. J. Virol. 82:8392-8399.
22. Imamoto N, et al. 1995. The nuclear pore-targeting complex binds to nuclear pores after association with a karyophile. FEBS Lett. 368:415-419.
23. Jenkins Y, McEntee M, Weis K, Greene WC. 1998. Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways. J. Cell Biol. 143:875-885.
24. Johannsen E, et al. 2004. Proteins of purified Epstein-Barr virus. Proc. Natl. Acad. Sci. U. S. A. 101:16286-16291.
25. Kaku N, Matsuda K, Tsujimura A, Kawata M. 2008. Characterization of nuclear import of the domain-specific androgen receptor in association with the importin alpha/beta and Ran-guanosine 5=-triphosphate systems. Endocrinology 149:3960-3969.
26. Kato K, et al. 2001. Epstein-Barr virus-encoded protein kinase BGLF4 mediates hyperphosphorylation of cellular elongation factor 1delta (EF-1delta): EF-1delta is universally modified by conserved protein kinases of herpesviruses in mammalian cells. J. Gen. Virol. 82:1457-1463.
27. Kato K, et al. 2003. Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function. J. Gen. Virol. 84:3381-3392.
28. Kawaguchi Y, et al. 2003. Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta. J. Virol. 77:2359-2368.
29. Kosako H, Imamoto N. 2010. Phosphorylation of nucleoporins: signal transduction-mediated regulation of their interaction with nuclear transport receptors. Nucleus 1:309-313.
30. Krajewski S, et al. 1993. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53:4701-4714.
31. Kudoh A, et al. 2006. Phosphorylation of MCM4 at sites inactivating DNA helicase activity of the MCM4-MCM6-MCM7 complex during Epstein-Barr virus productive replication. J. Virol. 80:10064-10072.
32. Leader DP. 1993. Viral protein kinases and protein phosphatases. Pharmacol. Ther. 59:343-389.
33. Lee CP, et al. 2007. Epstein-Barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II. J. Virol. 81:5166-5180.
34. Lee CP, Chen MR. 2010. Escape of herpesviruses from the nucleus. Rev. Med. Virol. 20:214-230.
35. Lee CP, et al. 2008. Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production. J. Virol. 82:11913-11926.
36. Le Rouzic E, et al. 2002. Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1. J. Biol. Chem. 277:45091-45098.
37. Li R, et al. 2012. SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function. J. Virol. 86:5412-5421.
38. Li R, et al. 2011. Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe 10:390-400.
39. Lu CC, Chen MR. 2006. Lytic replication of Epstein-Barr virus. Future Virol. 1:435-446.
40. Lu CC, Chen YC, Wang JT, Yang PW, Chen MR. 2007. Xeroderma pigmentosum C is involved in Epstein Barr virus DNA replication. J. Gen. Virol. 88:3234-3243.
41. Lu CC, et al. 2006. Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus. Virology 345:358-372.
42. Makarova O, Kamberov E, Margolis B. 2000. Generation of deletion and point mutations with one primer in a single cloning step. Biotechniques 29:970-972.
43. Marg A, et al. 2004. Nucleocytoplasmic shuttling by nucleoporins Nup153 and Nup214 and CRM1-dependent nuclear export control the subcellular distribution of latent Stat1. J. Cell Biol. 165:823-833.
44. Matsubayashi Y, Fukuda M, Nishida E. 2001. Evidence for existence of a nuclear pore complex-mediated, cytosol-independent pathway of nuclear translocation of ERK MAP kinase in permeabilized cells. J. Biol. Chem. 276:41755-41760.
45. Matunis MJ. 2006. Isolation and fractionation of rat liver nuclear envelopes and nuclear pore complexes. Methods 39:277-283.
46. Michel D, et al. 1998. Functional regions of the human cytomegalovirus protein pUL97 involved in nuclear localization and phosphorylation of ganciclovir and pUL97 itself. J. Gen. Virol. 79(Pt 9):2105-2112.
47. Mitchell DA, Marshall TK, Deschenes RJ. 1993. Vectors for the inducible overexpression of glutathione S-transferase fusion proteins in yeast. Yeast 9:715-722.
48. Moore MS, Schwoebel ED. 2001. Nuclear import in digitoninpermeabilized cells. Curr. Protoc. Cell Biol. Chapter 11:Unit 11.7.
49. Nie Z, et al. 1998. The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells. J. Virol. 72: 4104-4115.
50. Otsuka S, Iwasaka S, Yoneda Y, Takeyasu K, Yoshimura SH. 2008. Individual binding pockets of importin-beta for FG-nucleoporins have different binding properties and different sensitivities to RanGTP. Proc. Natl. Acad. Sci. U. S. A. 105:16101-16106.
51. Porter FW, Brown B, Palmenberg AC. 2010. Nucleoporin phosphorylation triggered by the encephalomyocarditis virus leader protein is mediated by mitogen-activated protein kinases. J. Virol. 84:12538-12548.
52. Robbins J, Dilworth SM, Laskey RA, Dingwall C. 1991. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 64: 615-623.
53. Sorokin AV, Kim ER, Ovchinnikov LP. 2007. Nucleocytoplasmic transport of proteins. Biochemistry (Mosc.) 72:1439-1457.
54. Wang JT, et al. 2009. Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway. J. Virol. 83:1856-1869.
55. Wang JT, et al. 2005. Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J. Gen. Virol. 86:3215-3225.
56. Webel R, et al. 2011. Two isoforms of the protein kinase pUL97 of human cytomegalovirus are differentially regulated in their nuclear translocation. J. Gen. Virol. 92:638-649.
57. Weis K, Ryder U, Lamond AI. 1996. The conserved amino-terminal domain of hSRP1 alpha is essential for nuclear protein import. EMBO J. 15:1818-1825.
58. Wente SR, Rout MP. 2010. The nuclear pore complex and nuclear transport. Cold Spring Harbor Perspect. Biol. 2:a000562.
59. Whitehurst AW, et al. 2002. ERK2 enters the nucleus by a carrierindependent mechanism. Proc. Natl. Acad. Sci. U. S. A. 99:7496-7501.
60. Wild P, et al. 2009. Exploring the nuclear envelope of herpes simplex virus 1-infected cells by high-resolution microscopy. J. Virol. 83:408-419.
61. Yang PW, Chang SS, Tsai CH, Chao YH, Chen MR. 2008. Effect of phosphorylation on the transactivation activity of Epstein-Barr virus BMRF1, a major target of the viral BGLF4 kinase. J. Gen. Virol. 89:884-895.
62. Yokoya F, Imamoto N, Tachibana T, Yoneda Y. 1999. beta-Catenin can be transported into the nucleus in a Ran-unassisted manner. Mol. Biol. Cell 10:1119-1131.
63. Yoon S, Seger R. 2006. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24: 21-44.
64. Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4:757-768.
65. Yue W, Gershburg E, Pagano JS. 2005. Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter. J. Virol. 79:5880-5885.
66. Zhu J, et al. 2009. Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4. J. Virol. 83:5219-5231.